Study of The Therapeutic Benefits of Al-hijamah in Children With Beta Thalassemia Major
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
1. Evaluate the therapeutic effects, health benefits, and immunological effect of
Al-hijamah in children with beta thalassemia major.
2. Evaluate the extent of clinical improvement, reductions in serum iron and ferritin,
antioxidant status, in those patients.